Updating concepts, Alzheimer's continuum is an umbrella term that include all individual with biomarkers evidence of Aβ deposition, independently from tau pathology or neurodegeneration, and the term “Alzheimer's disease” should be used only if there is evidence of both Aβ and tau pathology. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.